Amikacin

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Amikacin and local guidelines before prescribing.

Aminoglycoside antibiotic

Mechanism

Aminoglycoside binding the 30S ribosome to inhibit bacterial protein synthesis.

Uses

Serious Gram-negative infections resistant to gentamicin; some mycobacterial infections.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Nephrotoxicity, ototoxicity (vestibular and cochlear), neuromuscular blockade.

Interactions

Loop diuretics, ciclosporin and other nephrotoxic agents increase toxicity; neuromuscular blockers potentiated.

Contraindications and cautions

Myasthenia gravis; caution in renal impairment, hearing loss

Monitoring

Levels, creatinine, audiology on prolonged use

Pregnancy and breastfeeding

Avoid (fetal ototoxicity)

Renal and hepatic impairment

Dose by level in renal impairment

Overdose and reversal

Haemodialysis; calcium for neuromuscular block

Special advice

Monitor levels and renal function; adjust dose for renal impairment; avoid in myasthenia gravis.

More from the textbook: uses, cautions and other points
Where it is discussed in the book